J 2021

Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation

GIALLONGO, Sebastiano, Daniela ŘEHÁKOVÁ, Marco RAFFAELE, Oriana LO RE, Irena KOUTNÁ et. al.

Základní údaje

Originální název

Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation

Autoři

GIALLONGO, Sebastiano (380 Itálie, domácí), Daniela ŘEHÁKOVÁ (203 Česká republika, domácí), Marco RAFFAELE (380 Itálie), Oriana LO RE (380 Itálie), Irena KOUTNÁ (203 Česká republika, domácí) a Manlio VINCIGUERRA (380 Itálie, garant, domácí)

Vydání

ANTIOXIDANTS & REDOX SIGNALING, NEW ROCHELLE, MARY ANN LIEBERT, INC, 2021, 1523-0864

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10608 Biochemistry and molecular biology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 7.468

Kód RIV

RIV/00216224:14110/21:00120673

Organizační jednotka

Lékařská fakulta

UT WoS

000555879000001

Klíčová slova anglicky

induced pluripotent stem cells (iPSCs); oxidative stress; DNA damage

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 10. 2022 10:17, Mgr. Tereza Miškechová

Anotace

V originále

Significance:Since their discovery, induced pluripotent stem cells (iPSCs) had generated considerable interest in the scientific community for their great potential in regenerative medicine, disease modeling, and cell-based therapeutic approach, due to their unique characteristics of self-renewal and pluripotency. Recent Advances:Technological advances in iPSC genome-wide epigenetic profiling led to the elucidation of the epigenetic control of cellular identity during nuclear reprogramming. Moreover, iPSC physiology and metabolism are tightly regulated by oxidation-reduction events that mainly occur during the respiratory chain. In theory, iPSC-derived differentiated cells would be ideal for stem cell transplantation as autologous cells from donors, as the risks of rejection are minimal. Critical Issues:However, iPSCs experience high oxidative stress that, in turn, confers a high risk of increased genomic instability, which is most often linked to DNA repair deficiencies. Genomic instability has to be assessed before iPSCs can be used in therapeutic designs. Future Directions:This review will particularly focus on the links between redox balance and epigenetic modifications-in particular based on the histone variant macroH2A1-that determine DNA damage response in iPSCs and derived differentiated cells, and that might be exploited to decrease the teratogenic potential on iPSC transplantation.

Návaznosti

MUNI/A/1325/2020, interní kód MU
Název: Biomedicínské vědy
Investor: Masarykova univerzita, Biomedicínské vědy
90128, velká výzkumná infrastruktura
Název: CZECRIN III